Recurrent T acute lymphoblastic leukemia
Clinical trials for Recurrent T acute lymphoblastic leukemia explained in plain language.
Never miss a new study
Get alerted when new Recurrent T acute lymphoblastic leukemia trials appear
Sign up with your email to follow new studies for Recurrent T acute lymphoblastic leukemia, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a smart chemotherapy outsmart resistant T-Cell cancers?
Disease control OngoingThis trial tests an experimental drug called OBI-3424 in people with T-cell acute lymphoblastic leukemia or T-cell lymphoblastic lymphoma that has returned or not responded to treatment. The drug is designed to become active mainly inside cancer cells that produce a specific enzy…
Matched conditions: RECURRENT T ACUTE LYMPHOBLASTIC LEUKEMIA
Phase 1/2 • Sponsor: SWOG Cancer Research Network • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
Promising combo targets tough leukemia in early trial
Disease control OngoingThis study tests a combination of two drugs—venetoclax and vincristine—in people with T-cell or B-cell acute lymphoblastic leukemia that has returned or not responded to prior treatment. The goal is to find the safest dose and see if the combo can lead to remission. About 40 adul…
Matched conditions: RECURRENT T ACUTE LYMPHOBLASTIC LEUKEMIA
Phase 1/2 • Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC